Kurs
+4,82%
Kurs
+4,82%
Open
43,60
High
46,45
Low
43,60
Close
45,70
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
4,23 MNOK
Likviditet
4,23 MNOK
Rel. mcap
0,09%
Antal aktier
93 663
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2025-10-31 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-11 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-30 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-04-28 | N/A | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2025-04-25 | - | Årsstämma |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-11-01 | - | Kvartalsrapport 2024-Q3 |
| 2024-09-09 | - | X-dag ordinarie utdelning AKBM 45.00 NOK |
| 2024-09-03 | - | Extra Bolagsstämma 2024 |
| 2024-07-12 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-17 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2024-04-16 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-01 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2023-04-20 | - | Årsstämma |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-11-01 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-14 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-29 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2022-04-20 | - | Årsstämma |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-14 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-15 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2021-03-12 | - | Årsstämma |
| 2021-02-16 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-15 | - | Kvartalsrapport 2020-Q2 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Handel & varor |
| Industri | Dagligvaror |
2023-11-14 17:17:39
14 November 2023: Aker BioMarine's CEO, Matts Johansen, will be speaking at
Jefferies Healthcare Conference tomorrow 15 November 2023 at 11.00 CET.
Attached you will find the presentation.
For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.